Latest filing published 23 Dec 2024 for BioSyent Inc., €846k.
This profile gathers the share dealings of Sean Driscoll in BioSyent Inc. In total, 6 filings cover trades dated from 13 April 2023 to 23 December 2024.
The open-market record consists of 6 sales worth €6.5M, with no purchase. In 2024 alone, the filings show no purchases and 6 sales.
The newest entry dates from 23 December 2024: an open-market sale of €846k, in BioSyent Inc. Between a trade and the moment it shows up on SEDI, the median delay is 12 days. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations